v3.25.4
Net loss per share
 9 Months Ended
Dec. 31, 2025
Earnings Per Share [Abstract]  
Net loss per share Net loss per share
Basic and diluted net loss per share attributable to common stockholders was calculated as follows:
Three Months Ended December 31,Nine Months Ended December 31,
2025202420252024
Numerator:
Net loss $(70,930)$(66,340)$(240,723)$(173,167)
Denominator:
Weighted average common shares outstanding, basic and diluted92,187,581 83,498,892 91,874,481 77,113,695 
Net loss per share, basic and diluted$(0.77)$(0.79)$(2.62)$(2.25)
The 14,058,153 shares of the Company's common stock issuable upon exercise of pre-funded warrants described in Note 9 to these condensed consolidated financial statements are included as outstanding common stock in the calculation of basic and diluted net loss per share.
The Company’s potentially dilutive securities, which include stock options, unvested restricted and performance stock units and warrants to purchase shares of common stock that resulted from the conversion of warrants to purchase shares of series seed preferred stock existing before the Company's IPO, have been excluded from the computation of diluted net loss per share as the effect would be to reduce the net loss per share. Therefore, the weighted average number of common shares outstanding used to calculate both basic and diluted net loss per share is the same. The Company excluded the following
potential common shares, presented based on amounts outstanding at each period end, from the computation of diluted net loss per share for the periods indicated because including them would have had an anti-dilutive effect:
Three and Nine Months Ended December 31,
20252024
Options to purchase common stock11,927,970 10,213,861 
Unvested restricted and performance stock units
5,663,023 3,491,335 
Warrants to purchase common stock— 497,344 
17,590,993 14,202,540